Mhanni, A.; Boutin, M.; Stockl, F.; Johnston, J.; Barnes, J.; Duerksen, D.; Zimmer, L.; Auray-Blais, C.; Rockman-Greenberg, C.
Mass Spectrometry Evaluation of Biomarkers in the Vitreous Fluid in Gaucher Disease Type 3 with Disease Progression Despite Long-Term Treatment. Diagnostics 2020, 10, 69.
https://doi.org/10.3390/diagnostics10020069
AMA Style
Mhanni A, Boutin M, Stockl F, Johnston J, Barnes J, Duerksen D, Zimmer L, Auray-Blais C, Rockman-Greenberg C.
Mass Spectrometry Evaluation of Biomarkers in the Vitreous Fluid in Gaucher Disease Type 3 with Disease Progression Despite Long-Term Treatment. Diagnostics. 2020; 10(2):69.
https://doi.org/10.3390/diagnostics10020069
Chicago/Turabian Style
Mhanni, Aizeddin, Michel Boutin, Frank Stockl, Janine Johnston, Jeff Barnes, Donald Duerksen, Leanne Zimmer, Christiane Auray-Blais, and Cheryl Rockman-Greenberg.
2020. "Mass Spectrometry Evaluation of Biomarkers in the Vitreous Fluid in Gaucher Disease Type 3 with Disease Progression Despite Long-Term Treatment" Diagnostics 10, no. 2: 69.
https://doi.org/10.3390/diagnostics10020069
APA Style
Mhanni, A., Boutin, M., Stockl, F., Johnston, J., Barnes, J., Duerksen, D., Zimmer, L., Auray-Blais, C., & Rockman-Greenberg, C.
(2020). Mass Spectrometry Evaluation of Biomarkers in the Vitreous Fluid in Gaucher Disease Type 3 with Disease Progression Despite Long-Term Treatment. Diagnostics, 10(2), 69.
https://doi.org/10.3390/diagnostics10020069